MED
MEDIFAST INC
12.10$
-1.5%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +15.2% | -13.8% | +70.6% | +40.7% | +38.6% | +72.3% | -34.9% | +105.8% | -24.1% | -83.4% | -72.0% | |
| – | -11.6% | -24.0% | -22.1% | +5.4% | +4.3% | +57.2% | -6.3% | +61.2% | +19.4% | +32.8% | -18.1% | |
| – | -21.4% | +11.3% | +24.5% | -26.8% | +44.7% | +50.4% | +45.7% | +11.6% | -25.9% | -10.1% | +3.7% | |
| – | -111.8% | – | -39.8% | -87.2% | +1,902.7% | -16.5% | -24.2% | +98.0% | – | – | – | |
| – | – | -210.2% | – | -106.9% | – | – | -429.7% | – | -6.4% | -148.1% | – | |
| – | -59.9% | +2.0% | +12.7% | +52.4% | +103.6% | -41.5% | +481.1% | -51.2% | -61.1% | +15.0% | -24.7% | |
| – | -92.5% | +977.8% | +55.3% | -62.1% | +427.8% | -79.7% | +2,167.1% | -60.7% | +434.8% | -56.6% | -70.1% | |
| – | +0.0% | +0.0% | +29.4% | +50.5% | +52.8% | +50.3% | +20.1% | +12.2% | +2.0% | -99.0% | -72.7% | |
| – | -66.3% | -88.6% | +89.3% | +1,109.3% | +53.7% | -88.2% | +1,018.5% | +106.1% | -94.6% | -88.0% | -55.9% | |
| – | +14.9% | -14.1% | – | – | – | – | – | – | – | – | – | |
| – | -66.4% | +10.1% | +34.4% | +207.2% | +54.4% | -30.6% | +119.0% | +59.5% | -60.0% | -98.1% | -62.8% | |
| – | – | -40.8% | +117.7% | -72.2% | -169.8% | – | -168.6% | – | – | -152.0% | – | |
| – | +43.6% | -15.5% | +78.0% | +39.7% | +32.8% | +87.7% | -56.7% | +194.8% | -20.6% | -87.9% | -92.7% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.